Evidence map›Paper›PMID 28824821›Full record

ArticleACS catalysis2017

Mild and Regioselective Pd(OAc)

Alan J Reay, L Anders Hammarback, Joshua T W Bray, Thomas Sheridan, David Turnbull, Adrian C Whitwood, Ian J S Fairlamb

Abstract read
In one paragraph

Article in ACS catalysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Peptide modificationChemical science · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Peptide stapling by late-stage Suzuki-Miyaura cross-coupling.Beilstein journal of organic chemistry · 2022
    Article
  15. Article
  16. Article
  17. Late-Stage Diversification of Tryptophan-Derived Biomolecules.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020
    Review
  18. Late-stage C(spChemical science · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alan J ReayDepartment of Chemistry, University of York, York YO10 5DD, U.K.
L Anders HammarbackDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Joshua T W BrayDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Thomas SheridanDepartment of Chemistry, University of York, York YO10 5DD, U.K.
David TurnbullDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Adrian C WhitwoodDepartment of Chemistry, University of York, York YO10 5DD, U.K.
Ian J S FairlambDepartment of Chemistry, University of York, York YO10 5DD, U.K.

Funding

Wellcome Trust
6 · The paper itself

Abstract

A regioselective Pd-mediated C-H bond arylation methodology for tryptophans, utilizing stable aryldiazonium salts, affords C2-arylated tryptophan derivatives, in several cases quantitatively. The reactions proceed in air, without base, and at room temperature in EtOAc. The synthetic methodology has been evaluated and compared against other tryptophan derivative arylation methods using the CHEM21 green chemistry toolkit. The behavior of the Pd catalyst species has been probed in preliminary mechanistic studies, which indicate that the reaction is operating homogeneously, although Pd nanoparticles are formed during substrate turnover. The effects of these higher order Pd species on catalysis, under the reaction conditions examined, appear to be minimal: e.g., acting as a Pd reservoir in the latter stages of substrate turnover or as a moribund form (derived from catalyst deactivation). We have determined that TsOH shortens the induction period observed when [ArN

Indexed as

aryldiazonium saltchiralitycross-couplingdirecting groupheteroarenepalladiumregioselectivity

Identifiers

PMID28824821
PMCPMC5557615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.